TTOO Debt Ratio from 2010 to 2024

TTOO Stock

USD 0.58 0.01 1.75%

T2 Biosystms Debt Ratio yearly trend continues to be very stable with very little volatility. Debt Ratio is likely to grow to 1.29 this year. During the period from 2010 to 2024, T2 Biosystms Debt Ratio quarterly data regression pattern had sample variance of 0.19 and median of 0.57. View All Fundamentals

Debt Ratio

First Reported

2010-12-31

Previous Quarter

1.2328649

Current Value

1.29

Quarterly Volatility

0.43659039

Credit Downgrade

Yuan Drop

Covid

Check T2 Biosystms financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among T2 Biosystms' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 4.9 M or Total Revenue of 9.8 M, as well as many indicators such as Price To Sales Ratio of 2.16, Dividend Yield of 0.0 or Days Sales Outstanding of 131. TTOO financial statements analysis is a perfect complement when working with T2 Biosystms Valuation or Volatility modules.

Check out the analysis of T2 Biosystms Correlation against competitors.

To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.

Latest T2 Biosystms' Debt Ratio Growth Pattern

Below is the plot of the Debt Ratio of T2 Biosystms over the last few years. It is T2 Biosystms' Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in T2 Biosystms' overall financial position and show how it may be relating to other accounts over time.

Debt Ratio

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Debt Ratio

Timeline

TTOO Debt Ratio Regression Statistics

	Arithmetic Mean	0.74
	Geometric Mean	0.62
	Coefficient Of Variation	59.17
	Mean Deviation	0.35
	Median	0.57
	Standard Deviation	0.44
	Sample Variance	0.19
	Range	1.3474
	R-Value	0.75
	Mean Square Error	0.09
	R-Squared	0.56
	Significance	0
	Slope	0.07
	Total Sum of Squares	2.67

TTOO Debt Ratio History

	2024	1.29
	2023	1.23
	2022	1.48
	2021	0.79
	2020	0.57
	2019	1.51
	2018	0.66

Other Fundumenentals of T2 Biosystms

Cash Flow To Debt Ratio

T2 Biosystms Debt Ratio component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Net Tangible Assets	Current Deferred Revenue	Net Receivables	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.92	-0.33	-0.13	0.08	0.38	0.34	-0.56	0.97	-0.07	0.45	0.56	0.03	0.65	0.22	0.19	0.17	0.61	0.1	0.35	0.37	0.33
Total Stockholder Equity	0.92		-0.37	-0.09	0.02	0.35	0.17	-0.83	0.92	0.04	0.31	0.47	0.03	0.63	0.09	0.13	0.11	0.62	0.09	0.26	0.19	0.17
Net Debt	-0.33	-0.37		-0.81	0.59	0.53	0.38	0.26	-0.51	0.36	0.36	0.48	-0.84	-0.41	0.72	0.54	0.8	-0.51	0.77	-0.59	0.12	0.17
Retained Earnings	-0.13	-0.09	-0.81		-0.57	-0.8	-0.28	0.1	0.03	-0.53	-0.36	-0.78	0.95	0.12	-0.7	-0.68	-0.93	0.22	-0.86	0.61	-0.05	-0.05
Accounts Payable	0.08	0.02	0.59	-0.57		0.61	0.37	0.04	-0.05	0.26	0.59	0.4	-0.62	-0.12	0.76	0.6	0.6	-0.25	0.57	-0.53	-0.01	0.44
Long Term Debt	0.38	0.35	0.53	-0.8	0.61		0.32	-0.23	0.24	0.28	0.45	0.77	-0.7	0.03	0.67	0.94	0.86	-0.06	0.69	-0.46	0.15	0.18
Short Term Investments	0.34	0.17	0.38	-0.28	0.37	0.32		0.13	0.18	-0.26	0.83	0.43	-0.11	-0.14	0.77	0.34	0.44	-0.2	0.33	0.31	0.76	0.81
Total Liab	-0.56	-0.83	0.26	0.1	0.04	-0.23	0.13		-0.6	-0.26	-0.01	-0.25	0.08	-0.42	0.08	0.0	-0.02	-0.44	-0.07	-0.03	0.17	0.15
Total Current Assets	0.97	0.92	-0.51	0.03	-0.05	0.24	0.18	-0.6		-0.08	0.31	0.39	0.18	0.65	0.04	0.06	-0.01	0.64	-0.06	0.42	0.26	0.22
Short Term Debt	-0.07	0.04	0.36	-0.53	0.26	0.28	-0.26	-0.26	-0.08		-0.13	0.21	-0.64	0.03	0.1	0.16	0.4	0.05	0.63	-0.39	-0.56	-0.38
Common Stock	0.45	0.31	0.36	-0.36	0.59	0.45	0.83	-0.01	0.31	-0.13		0.52	-0.24	0.06	0.87	0.41	0.52	-0.05	0.48	0.21	0.73	0.94
Property Plant Equipment	0.56	0.47	0.48	-0.78	0.4	0.77	0.43	-0.25	0.39	0.21	0.52		-0.64	0.41	0.6	0.6	0.83	0.27	0.66	-0.27	0.32	0.26
Net Tangible Assets	0.03	0.03	-0.84	0.95	-0.62	-0.7	-0.11	0.08	0.18	-0.64	-0.24	-0.64		0.14	-0.61	-0.58	-0.87	0.24	-0.88	0.75	0.13	0.07
Current Deferred Revenue	0.65	0.63	-0.41	0.12	-0.12	0.03	-0.14	-0.42	0.65	0.03	0.06	0.41	0.14		-0.22	-0.13	-0.1	0.95	-0.09	0.25	0.0	-0.01
Net Receivables	0.22	0.09	0.72	-0.7	0.76	0.67	0.77	0.08	0.04	0.1	0.87	0.6	-0.61	-0.22		0.65	0.77	-0.33	0.71	-0.18	0.54	0.71
Long Term Debt Total	0.19	0.13	0.54	-0.68	0.6	0.94	0.34	0.0	0.06	0.16	0.41	0.6	-0.58	-0.13	0.65		0.78	-0.22	0.56	-0.42	0.16	0.21
Capital Surpluse	0.17	0.11	0.8	-0.93	0.6	0.86	0.44	-0.02	-0.01	0.4	0.52	0.83	-0.87	-0.1	0.77	0.78		-0.2	0.9	-0.5	0.24	0.24
Deferred Long Term Liab	0.61	0.62	-0.51	0.22	-0.25	-0.06	-0.2	-0.44	0.64	0.05	-0.05	0.27	0.24	0.95	-0.33	-0.22	-0.2		-0.14	0.34	-0.02	-0.1
Short Long Term Debt	0.1	0.09	0.77	-0.86	0.57	0.69	0.33	-0.07	-0.06	0.63	0.48	0.66	-0.88	-0.09	0.71	0.56	0.9	-0.14		-0.44	0.14	0.19
Net Invested Capital	0.35	0.26	-0.59	0.61	-0.53	-0.46	0.31	-0.03	0.42	-0.39	0.21	-0.27	0.75	0.25	-0.18	-0.42	-0.5	0.34	-0.44		0.51	0.4
Net Working Capital	0.37	0.19	0.12	-0.05	-0.01	0.15	0.76	0.17	0.26	-0.56	0.73	0.32	0.13	0.0	0.54	0.16	0.24	-0.02	0.14	0.51		0.77
Capital Stock	0.33	0.17	0.17	-0.05	0.44	0.18	0.81	0.15	0.22	-0.38	0.94	0.26	0.07	-0.01	0.71	0.21	0.24	-0.1	0.19	0.4	0.77

Click cells to compare fundamentals

About T2 Biosystms Financial Statements

T2 Biosystms investors utilize fundamental indicators, such as Debt Ratio, to predict how TTOO Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Debt Ratio	1.23	1.29
Cash Flow To Debt Ratio	(1.12)	(1.18)

When determining whether T2 Biosystms offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of T2 Biosystms' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of T2 Biosystms Stock. Outlined below are crucial reports that will aid in making a well-informed decision on T2 Biosystms Stock:

How To Invest In TTOO

Details

Is TTOO Stock a good investment?

Details

What is T2 Biosystms' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of T2 Biosystms Correlation against competitors.

To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.

You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.03)

Revenue Per Share

0.999

Quarterly Revenue Growth

(0.01)

Return On Assets

(0.90)

Return On Equity

(6.22)

The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

TTOO Debt Ratio from 2010 to 2024

Latest T2 Biosystms' Debt Ratio Growth Pattern

TTOO Debt Ratio Regression Statistics

TTOO Debt Ratio History

Other Fundumenentals of T2 Biosystms

T2 Biosystms Debt Ratio component correlations

About T2 Biosystms Financial Statements

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY